Landauer Inc

Landauer — Merger or Acquisition (November 2011)

15 slides from Landauer's merger presentation, Nov 15, 2011

  1. Slide 1: Acquisition of IZI Medical Products, LLC

    LANDAUER, INC. Acquisition of IZI Medical Products, LLC November 14, 2011

  2. Slide 2: Safe Harbor Statement

    This presentation may contain forward-looking statements, including statements about the outlook and prospects for Company and industry growth, as well as statements about the Company’s future financial and operating performance. Some of the information shared here constitutes forward-looking statem

  3. Slide 3: Agenda

    Agenda 61550; Introduction  Landauer Strategic Plan Overview  Acquisition Criteria  IZI Medical Products Overview  Transaction Overview  LDR Dividend Policy  Fiscal 2011 Guidance  Q&A Session 3

  4. Slide 4: Introduction

    Introduction  Landauer, Inc. (“Landauer”or the “Company”) is the global leader in radiation science and services ― Occupational Radiation Monitoring ― Medical Physics Radiation Management  IZI Medical Products, LLC (“IZI”or “IZI Medical Products”) is a leading provider of high quality medical cons

  5. Slide 5: Landauer Strategy Overview

    Value Creation Deliver Upside Growth 1.Optimize Core 2.Competitive Growth 3. Strategic Expansion Strategic Priorities Landauer Strategy Overview Strategic Expansion 2006 -2010 2010 and Beyond Optimize the Core Competitive Growth  New Management  Restructure: Cost  IT/ERP system upgrades  OSL / I

  6. Slide 6: Acquisition Criteria – Core Business

    Pursue Accretive Acquisitions  Market characteristics: ―Growth > GDP ―Market leader in unique or niche market ―Significant market opportunity  Leverages/expands competencies ―Healthcare preference Acquisition Criteria –Core Business  Demonstrated ability to identify, acquire, and seamlessly integ

  7. Slide 7: IZI at a Glance

    IZI at a Glance  1991 Founded  Baltimore, MD Headquarters  30 Employees  $14M Revenue YTD (nine months ended 9/30)  100% Recurring Revenue  1,000+ Annual Customers Served ($ in millions) History of Strong Revenue Growth Company Overview  Provides high quality medical accessories used in Radio

  8. Slide 8: IZI Medical Products Overview

    IZI Medical Products Overview  Spherz® ― Sterile, disposable passive reflective markers aid registration and instrument tracking during image guided surgery procedures  Multi-Modality Markers ― Artificial reference points used on radiology image to provide clear and accurate reference point on sca

  9. Slide 9: IZI – Market Overview

    IZI –Market Overview 9  Serves the attractive Radiation Oncology, Radiology, and Image Guided Surgery end markets  Image Guided Surgery global market continues to reflect strong growth opportunity ― Image Guided Surgery navigation technology can be used in a variety of medical specialties –Neurosu

  10. Slide 10: IZI – Broad and Diverse Customer Base

    IZI –Broad and Diverse Customer Base  IZI’s customer base includes buyers at several stages along the supply chain including distributors, manufacturers of image guided navigation equipment, and product end users  Targets community hospitals, radiation oncology clinics, mammography clinics, and im

  11. Slide 11: Transaction Overview

    Transaction Overview  Acquired 100% of the outstanding equity of IZI Medical Products for approximately $93 million cash, subject to certain customary purchase price adjustments  The acquisition is expected to be $0.12 to $0.16 accretive to EPS (earnings per share) in fiscal 2012  Acquisition may

  12. Slide 12: LDR Dividend Policy

    12 LDR Dividend Policy  We are committed to maintaining a competitive dividend and will continue to return cash to shareholders in this manner going forward  Board of Directors declared a regular quarterly cash dividend of$0.55 per share for the first quarter of fiscal 2012 – This represents an an

  13. Slide 13: Fiscal 2011 Guidance

    13 Fiscal 2011 Guidance  Affirm Fiscal 2011 Guidance (provided during fiscal third quarter earnings call) – Fiscal 2011 consolidated revenue –$120 to $126 million – Fiscal 2011 net income –$24 to $26 million  Full quarterly and annual results as well as an outline for fiscal 2012 guidance will be

  14. Slide 14: Transaction Rationale

    14 Transaction Rationale  IZI represents a logical extension of Landauer’s radiation safety continuum ― Significant channel leverage in U.S. and international markets for expanded product offering ― Enhances complementary product / service offerings ― Accretive both financially and operationally ―

  15. Slide 15: Questions?

    LANDAUER Questions?

Landauer — Merger or Acquisition (November 2011) on 6ix